SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.065-2.1%9:49 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
erippetoe
From: luckydog885/12/2025 8:24:37 AM
1 Recommendation  Read Replies (1) of 1229
 
knew this was coming again :)

D. Boral Capital analyst Jason Kolbert maintains ImmunityBio(IBRX) with a Buy and maintains $30 price target .... though his ranking as analyst is pretty sad - guess it makes sense his repeated buy "calls" never move the stock price:

Jason Kolbert
D. Boral Capital

Wall Street Analyst

#9,354 out of 9,504 Wall Street Analysts
#37,172 out of 40,592 experts
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext